EIR Ventures Overview
Eir Ventures is a life science-focused venture capital firm with a strong foundation in the Nordic biotech ecosystem. The firm invests in early-stage and more mature opportunities, focusing on companies addressing significant unmet medical needs through new therapies, medical technology, and digital health. Eir Ventures collaborates closely with leading Nordic universities and incubators to source high-potential opportunities.
Is EIR Ventures the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with EIR Ventures, along with a list of other relevant VCs, is available on Hopohopo.io.
EIR Ventures
Investment focus
Invest in
- Nordics
Product type
- Software
- Hardware
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
- MedTech & Devices
- PharmaTech
Investment role
Lead and follow
Stages
Series A, Series B or later
First ticket size
€100,000 - €1,500,000
Contact information
Principal
Lovisa Backemar
Founding Partner
Stephan Christgau
Investment Associate
Goekce Guenaydin
Global Head of BD
Amanda Hayward
Founding Partner
Magnus Persson
How to approach funds like EIR Ventures
When approaching Eir Ventures, founders should highlight robust clinical or preclinical data and a clear path to address substantial unmet medical needs. Demonstrating strong ties to the Nordic innovation ecosystem or collaborations with regional academic institutions can be a differentiator. Eir Ventures values teams with deep scientific expertise and a well-articulated regulatory and commercialization strategy, especially for ventures with global potential.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
